Primary data · sourced from public filings·700+ listed companies · India-first·Claude API · Healthy · —msOpen screener
Aletheia
ScreenerDisclosuresReportsMREEarningsNewsInsightsGlossary
✦Zeptoraises$340Mseries-c·Inc42✦Rapidoraises$120Mseries-b·YourStory✦Krutrimraises$50Mseries-a·Entrackr✦Perfiosraises$80Mseries-b·VCCircle✦Zetwerkraises$210Mseries-d·Inc42✦Amagiraises$100Mseries-c·YourStory✦Sarvam AIraises$41Mseries-a·Entrackr✦Leap Financeraises$55Mseries-b·VCCircle✦Zeptoraises$340Mseries-c·Inc42✦Rapidoraises$120Mseries-b·YourStory✦Krutrimraises$50Mseries-a·Entrackr✦Perfiosraises$80Mseries-b·VCCircle✦Zetwerkraises$210Mseries-d·Inc42✦Amagiraises$100Mseries-c·YourStory✦Sarvam AIraises$41Mseries-a·Entrackr✦Leap Financeraises$55Mseries-b·VCCircle

Aletheia · Disclosure Card

Cipla

CIPLA · Pharma

MARKET CAP

₹1.1L Cr

PE

24.8x

PB

4.2x

ROE

16.8%

REV GROWTH

10.4%

DISCLOSURE HEALTH SCORE

78/100
ACCEPTABLE

Passes most checks. Verify the noted areas before increasing position.

01ADEQUATE
18.4%ADEQUATE14/20

ROCE of 18.4% clears the threshold but has limited spread over WACC. Monitor trajectory.

02ADEQUATE
1.14ADEQUATE14/20

OCF/PAT ratio of 1.14 — broadly in line with profit. Minor non-cash items at play.

03CLEAN
0% pledgedCLEAN20/20

No promoter pledge. Promoter holding is unencumbered — full alignment with minority shareholders.

04CONSERVATIVE
D/E 0.1xCONSERVATIVE16/20

D/E of 0.1x. Conservative leverage. Cash flows easily service debt.

05ADEQUATE
2.4% FCF yieldADEQUATE14/20

FCF yield of 2.4%. Positive cash generation. Adequate for dividend or selective buyback.

← BACK TO SCREENERSECTOR PE →GET FULL AUDIT →

Data is representative and for educational purposes only. Not investment advice. Verify all data on Screener.in, BSE, or NSE before any investment decision.

AletheiaAI — The truth layer for India's public markets. 700+ companies, scored.